Svar Life Science

March 21, 2023

Next-Generation Complement Therapeutics — Exploring Challenges and Solutions from Bench to Bedside, Upcoming Webinar featuring Svar Life Science

Are you interested in learning more about the promising field of complement therapeutics?

Look no further than this Xtalks free webinar, where attendees will gain valuable insights into the different stages of drug development and the experiences of academics and industry experts within these stages.

To read the full press release

March 21, 2023

Next-Generation Complement Therapeutics — Exploring Challenges and Solutions from Bench to Bedside, Upcoming Webinar featuring Svar Life Science

Are you interested in learning more about the promising field of complement therapeutics?

Look no further than this Xtalks free webinar, where attendees will gain valuable insights into the different stages of drug development and the experiences of academics and industry experts within these stages.

To read the full press release

COMPLEMENT THERAPEUTICS
ON THE RISE

The complement system has recently gained more attention as an important and integral part of the immune system that interacts with a wide range of tissues and cells.

The rise in the number of conditions linked to dysregulation of the complement system underscores the potential of complement-modulating therapeutics. However, developing effective drugs has been challenging, and many attempts have failed.

The upcoming panel discussion will provide attendees with insights and perspectives on the challenges and potentials of complement therapeutics from drug discovery through clinical testing.

The discussion will feature experts in the field who will share their experiences and knowledge on next-generation complement therapeutics.

Register for the webinar to learn more about novel complement-modulating drugs and how they can improve patients' health.

GAIN INSIGHT FROM COMPLEMENT EXPERTS

During the webinar,  Dr. Christoph Schmidt, Professor of Biochemical Pharmacy, Institute of Pharmacy, Martin-Luther University of Halle-Wittenberg; Dr. Előd Körtvély, Principal Scientist, Pharma Research and Early Development (pRED), Roche Innovation Center; Dr. Sandra Wymann, Senior Manager, Translational Research, CSL Behring AG and Dr. Michael Schwenkert, Chief Technology Officer, Svar Life Science, will discuss both the challenges and potentials of modern therapeutics, highlighting the importance of functional assays in drug development. 

With a focus on next-generation complement therapeutics, attendees will learn about the tools used to support the development of innovative treatments that could revolutionize patient care.

Take advantage of this opportunity to expand your knowledge of the complement therapeutics landscape - register for the webinar today.

Register today!